Severe adverse effects such as pancreatitis, transaminitis, cholelithiasis, COVID19 pneumonia, hypoglycemia, and injection site reactions, were more common in people taking Tirzepatide than in those taking Semaglutide
However, higher-dose Wegovy injections may produce greater average weight loss in some patients
Accordingly, one plausible interpretation is that GLP-1RAs may reduce the overall subjective appeal of food through satiety-related interoceptive signals and attenuation of hunger drive, thereby manifesting as changes in liking (60)
This optional intermediate step exists primarily for individuals who tolerate 10 mg well but have not achieved desired weight loss goals
NDC: 00169-4181-13
We proudly accept insurance and manage prior authorizations, allowing you to prioritize your health